259 related articles for article (PubMed ID: 15911947)
41. [Characteristics of action of various drugs blocking atrioventricular conduction (beta-blockers, verapamil, diltiazem) in constant fibrillation tachyarrhythmia. Is monotherapy optimal?].
Blagova OV; Nedostup AV
Ter Arkh; 2006; 78(8):30-8. PubMed ID: 17078214
[TBL] [Abstract][Full Text] [Related]
42. Effects of a high dose intravenous bolus amiodarone in patients with atrial fibrillation and a rapid ventricular rate.
Hofmann R; Steinwender C; Kammler J; Kypta A; Leisch F
Int J Cardiol; 2006 Jun; 110(1):27-32. PubMed ID: 16046015
[TBL] [Abstract][Full Text] [Related]
43. Intravenous metoprolol versus diltiazem for atrial fibrillation with concomitant heart failure.
Compagner CT; Wysocki CR; Reich EK; Zimmerman LH; Holzhausen JM
Am J Emerg Med; 2022 Dec; 62():49-54. PubMed ID: 36252310
[TBL] [Abstract][Full Text] [Related]
44. Calcium channel blockers improve exercise capacity and reduce N-terminal Pro-B-type natriuretic peptide levels compared with beta-blockers in patients with permanent atrial fibrillation.
Ulimoen SR; Enger S; Pripp AH; Abdelnoor M; Arnesen H; Gjesdal K; Tveit A
Eur Heart J; 2014 Feb; 35(8):517-24. PubMed ID: 24135831
[TBL] [Abstract][Full Text] [Related]
45. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.
Okin PM; Wachtell K; Kjeldsen SE; Julius S; Lindholm LH; Dahlöf B; Hille DA; Nieminen MS; Edelman JM; Devereux RB
Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):337-43. PubMed ID: 19808428
[TBL] [Abstract][Full Text] [Related]
46. Ibutilide to expedite ED therapy for recent-onset atrial fibrillation flutter.
Mountantonakis SE; Moutzouris DA; Tiu RV; Papaioannou GN; McPherson CA
Am J Emerg Med; 2006 Jul; 24(4):407-12. PubMed ID: 16787796
[TBL] [Abstract][Full Text] [Related]
47. Double-blind crossover randomized trial of intravenously administered verapamil. Its use for atrial fibrillation and flutter following open heart surgery.
Hwang MH; Danoviz J; Pacold I; Rad N; Loeb HS; Gunnar RM
Arch Intern Med; 1984 Mar; 144(3):491-4. PubMed ID: 6703818
[TBL] [Abstract][Full Text] [Related]
48. Left ventricular performance during acute rate control in atrial fibrillation: the importance of heart rate and agent used.
Pinter A; Dorian P; Paquette M; Ng A; Burns M; Spanu I; Freeman M; Korley V; Newman D
J Cardiovasc Pharmacol Ther; 2003 Mar; 8(1):17-24. PubMed ID: 12652326
[TBL] [Abstract][Full Text] [Related]
49. Comparison of intravenous ibutilide vs. propafenone for rapid termination of recent onset atrial fibrillation.
Zhang N; Guo JH; Zhang HCh; Li XB; Zhang P; Xn Y
Int J Clin Pract; 2005 Dec; 59(12):1395-400. PubMed ID: 16351670
[TBL] [Abstract][Full Text] [Related]
50. Acute management of atrial fibrillation in congestive heart failure with reduced ejection fraction in the emergency department.
Hasbrouck M; Nguyen TT
Am J Emerg Med; 2022 Aug; 58():39-42. PubMed ID: 35623182
[TBL] [Abstract][Full Text] [Related]
51. Low-dose intravenous diltiazem--efficacy and safety in supraventricular tachyarrhythmias.
Seth S; Mittal A; Goel P; Wasir HS
Indian Heart J; 1996; 48(4):365-7. PubMed ID: 8908822
[TBL] [Abstract][Full Text] [Related]
52. [Increased vagal activity after administration of the calcium antagonist diltiazem in patients with coronary heart disease].
Frey AW; Müller C; Dambacher M; Theisen K
Z Kardiol; 1995 Feb; 84(2):105-11. PubMed ID: 7717013
[TBL] [Abstract][Full Text] [Related]
53. Management of Atrial Fibrillation with Rapid Ventricular Response in the Intensive Care Unit: A Secondary Analysis of Electronic Health Record Data.
Moskowitz A; Chen KP; Cooper AZ; Chahin A; Ghassemi MM; Celi LA
Shock; 2017 Oct; 48(4):436-440. PubMed ID: 28328711
[TBL] [Abstract][Full Text] [Related]
54. Rate-control drugs affect variability and irregularity measures of RR intervals in patients with permanent atrial fibrillation.
Corino VD; Ulimoen SR; Enger S; Mainardi LT; Tveit A; Platonov PG
J Cardiovasc Electrophysiol; 2015 Feb; 26(2):137-41. PubMed ID: 25367150
[TBL] [Abstract][Full Text] [Related]
55. Etiology, pathophysiology, and treatment of atrial fibrillation: part 1.
Aronow WS
Cardiol Rev; 2008; 16(4):181-8. PubMed ID: 18562808
[TBL] [Abstract][Full Text] [Related]
56. Clinical factors that influence response to treatment strategies in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
Curtis AB; Gersh BJ; Corley SD; DiMarco JP; Domanski MJ; Geller N; Greene HL; Kellen JC; Mickel M; Nelson JD; Rosenberg Y; Schron E; Shemanski L; Waldo AL; Wyse DG;
Am Heart J; 2005 Apr; 149(4):645-9. PubMed ID: 15990747
[TBL] [Abstract][Full Text] [Related]
57. [Factors for successful conversion of atrial fibrillation using intravenous injection of pilsicainide hydrochloride].
Matsushita K; Ishikawa T; Sumita S; Kobayashi T; Matsumoto K; Yamakawa Y; Ohkusu Y; Nakagawa T; Nakazawa I; Mochida Y; Ebina T; Uchino K; Kimura K; Umemura S
J Cardiol; 2003 Aug; 42(2):81-6. PubMed ID: 12964518
[TBL] [Abstract][Full Text] [Related]
58. Intravenous administration of metoprolol is more effective than oral administration in the prevention of atrial fibrillation after cardiac surgery.
Halonen J; Hakala T; Auvinen T; Karjalainen J; Turpeinen A; Uusaro A; Halonen P; Hartikainen J; Hippeläinen M
Circulation; 2006 Jul; 114(1 Suppl):I1-4. PubMed ID: 16820555
[TBL] [Abstract][Full Text] [Related]
59. Outcome of pharmacological rhythm control for new-onset persistent atrial fibrillation in patients with systolic heart failure: a comparison with patients with normal left ventricular function.
Hemels ME; Wiesfeld AC; Van Veldhuisen DJ; Van den Berg MP; Van Gelder IC
Europace; 2007 Apr; 9(4):239-45. PubMed ID: 17332026
[TBL] [Abstract][Full Text] [Related]
60. Intravenous Metoprolol Versus Diltiazem for Rate Control in Atrial Fibrillation.
Xiao SQ; Ibarra F; Cruz M
Ann Pharmacother; 2022 Aug; 56(8):916-921. PubMed ID: 34738470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
